Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
VahatiCor Secures $23M Series B to Advance Cardiac Care Technology
Series BVenture Capital

VahatiCor Secures $23M Series B to Advance Cardiac Care Technology

•November 18, 2025
•Nov 18, 2025

Participants

VahatiCor

VahatiCor

company

S3 Ventures

S3 Ventures

investor

Intuitive Surgical

Intuitive Surgical

investor

Why It Matters

The funding fast‑tracks development of the only dedicated treatment for CMD, opening a sizable unmet market and offering a therapeutic option for patients who currently have none, while underscoring strong investor confidence in cardiovascular innovation.

Deal Summary

VahatiCor announced the closing of a $23 million Series B round led by S3 Ventures with participation from Intuitive Ventures and a strategic investor. The funding will support enrollment in the SERRA‑I trial, engineering development, and preparation for pivotal studies and regulatory interactions.

Comments

Want to join the conversation?

Loading comments...